CellRapeutics™ Leukopak from Alpha-Gal Syndrome Donor (XS-0426-XU226)

Name: CellRapeutics™ Leukopak from Alpha-Gal Syndrome Donor
SKU: XS-0426-XU226
Rating: 5 (1 reviews)

Online Inquiry Datasheet

All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.

This specialized Leukopak is harvested from donors with Alpha-Gal Syndrome, triggered by tick-mediated sensitization to galactose-alpha-1,3-galactose. The specimen provides a unique source of B cells and T cells that maintain a specific memory for carbohydrate epitopes. It is an invaluable resource for studying non-protein allergen recognition and the atypical immunological pathways of carbohydrate-induced anaphylaxis.

Specific Inquiry

Add to Cart

Donor Information

Product Name
CellRapeutics™ Leukopak from Alpha-Gal Syndrome Donor

Cat. No.
XS-0426-XU226

Donor Age
Middle-Aged

Donor Health
Donors present with a specific carbohydrate-targeted allergy. The immune profile is marked by the presence of memory cells sensitized to Galactose-alpha-1,3-galactose, typically following tick-mediated sensitization.

Ethnicity
Diverse backgrounds available.

Anticoagulant
Acid Citrate Dextrose, strictly controlled to ensure no carbohydrate-based interference while preserving sensitive IgE-mediated cellular responses.

Additional Donor Information
Each lot features a Leukopak from donors with Alpha-Gal syndrome. Profiles include tick infestation history and specific IgE titers to galactose-alpha-1,3-galactose for studying delayed allergic reactions.

Clinical Profile
History of tick infestation, severity of reaction to red meat/mammalian products, and Alpha-gal IgE levels.

Additional Information

Medication History
Available upon request. Documentation of mammalian-product-free diet adherence and use of emergency medications or antihistamines for acute reactions.

Formulation
Cryopreserved or Fresh options available.

Cell Purity
>90%

Cell Viability
>90%

Mycoplasma Testing
Negative

Sterility Testing
Negative

Genetic Stability Testing
The donor cells maintain their native genetic profile, exhibiting no karyotypic abnormalities or chromosomal instabilities typically associated with prolonged ex vivo expansion.

Application
Drug Discovery, Immuno-oncology Research

Research Use Only
RUO

Quality Control
Each product batch is strictly validated for high cellular viability, specific immune cell counts, and pathogen-free safety, ensuring consistent clinical phenotypes and ethical compliance for advanced immunological research.

Storage
Store fresh Leukopaks at 2°C to 8°C for immediate use, cryopreserved samples must be kept in liquid nitrogen vapor phase below -150°C.

Shiping
Dry Ice

Handling Notes
Process fresh cells within 48 hours or perform rapid thawing of cryovials in a 37°C water bath followed by gradual dilution to maximize recovery.

Warnings
Treat as potentially biohazardous human-derived material and handle strictly under BSL-2 guidelines using appropriate personal protective equipment.

Size
Full Bag, Half Bag

Keywords
CellRapeutics™ Leukopak from Alpha-Gal Syndrome Donor, Leukopak, Alpha-Gal Syndrome

Case Studies

Customer Reviews and Q&As

There are currently no customer reviews or questions for CellRapeutics™ Leukopak from Alpha-Gal Syndrome Donor (XS-0426-XU226). Click the button below to contact us or submit your feedback about this product.

For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.